as on October 31, 2025 at 1:05 am IST
52 Week's Low
52 Week's High

82.00%
Downside
105.50%
Upside

Check Psyence Biomedical Equity Warrants Exp 22 Jan 2029 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.9M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| NA | $6.9M | NA | NA | 0.00% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 investment value today
Current value as on today
₹72,308
Returns
Returns from Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock
Dollar Returns*
₹5,642 (+5.64%)
Investment in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Shares on INDmoney has dropped by -0.82% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 201.1%
 NEGATIVE IMPACT
NEGATIVE IMPACTPrice Dip

In the last 7 days, PBMWW stock has moved down by -13.7%
| Organisation | Psyence Biomedical Equity Warrants Exp 22 Jan 2029 | 
| Headquarters | 121 Richmond Street West, Toronto, ON, Canada, M5H2K1 | 
| CEO | Mr. Jody Aufrichtig | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Neil Maresky M.D. | Global Head of Clinical Development | 
| Ms. Taryn Vos | General Counsel | 
| Mr. Jody Aufrichtig | Co-Founder, Executive Chairman & CEO | 
| Mr. Warwick Ron Corden-Lloyd | Chief Financial Officer | 
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today is $0.02 as on at the close of the market. Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share today touched a day high of $0.02 and a low of $0.02.
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share touched a 52 week high of $0.04 on and a 52 week low of $0 on . Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock price today i.e. is closed at $0.02,which is 51.34% down from its 52 week high and 455.56% up from its 52 week low.
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 market capitalisation is $0.00T as on .
Indian investors can start investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share’s latest price of $0.02 as on October 31, 2025 at 1:05 am IST, you will get 500.0000 shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029. Learn more about
          
            fractional shares .